Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor

Nature Communications

Volumn 6, Issue , 2015, Pages

  Liu, Ying ^a   Chen, Chunying ^a   Qian, Pengxu ^b   Lu, Xuefei ^b   Sun, Baoyun ^a   Zhang, Xiao ^b   Wang, Liming ^a   Gao, Xingfa ^a   Li, Han ^a   Chen, Zhiyun ^a   Tang, Jinglong ^a   Zhang, Weijie ^b   Dong, Jinquan ^a   Bai, Ru ^a   Lobie, Peter E ^b,c   Wu, Qingfa ^b   Liu, Suling ^b   Zhang, Huafeng ^b   Zhao, Feng ^a   Wicha, Max S ^d   Zhu, Tao ^b   Zhao, Yuliang ^a   more..

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM METALLOFULLERENOL NANOMATERIAL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PACLITAXEL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; FULLERENE DERIVATIVE; GADOLINIUM; HIF1A PROTEIN, HUMAN; NANOMATERIAL;

ALCOHOL; BIOENGINEERING; CANCER; CELL ORGANELLE; HYDROXYL RADICAL; INHIBITOR; SIGNALING; TOXICITY; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM CELL; CANCER SIZE; CANCER STEM CELL; CANCER THERAPY; CELL DEATH; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HYDROXYLATION; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NANOMEDICINE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL ADHESION; CELL MOTION; CHEMISTRY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; METASTASIS; PROCEDURES; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FULLERENES; GADOLINIUM; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NANOMEDICINE; NANOSTRUCTURES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84923166604     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6988     Document Type: Article

References (52)

1. Kang, S. G. et al. Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine. Proc. Natl Acad. Sci. USA 109, 15431-15436 (2012).
2. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760 (2007).
3. Ge, Z. & Liu, S. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chem. Soc. Rev. 42, 7289-7325 (2013).
4. Tang, J. et al. Periodical variation of electronic properties in polyhydroxylated metallofullerene materials. Adv. Mater. 18, 1458-1462 (2006).
5. Miyamoto, A., Okimoto, H., Shinohara, H. & Shibamoto, Y. Development of water-soluble metallofullerenes as X-ray contrast media. Eur. Radiol. 16, 1050-1053 (2006).
6. Xu, L. et al. Morphologically virus-Like fullerenol nanoparticles act as the dualfunctional nanoadjuvant for HIV-1 vaccine. Adv. Mater. 25, 5928-5936 (2013).
7. Liu, Y. et al. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/ Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials 30, 3934-3945 (2009).
8. Meng, H. et al. Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells. Nanomedicine 8, 136-146 (2012).
9. Chen, C. et al. Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett. 5, 2050-2057 (2005).
10. Clevers, H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313-319 (2011).
11. Nguyen, D. X., Bos, P. D. & Massagué, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284 (2009).
12. Park, C. Y., Tseng, D. & Weissman, I. L. Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol. Ther. 17, 219-230 (2009).
13. Malik, F., Korkaya, H., Clouthier, S. G. & Wicha, M. S. Breast cancer heterogeneity: need to review current treatment strategies. Curr. Breast Cancer Rep. 4, 225-231 (2012).
14. Ganesan, S., Karantza, V., Oza, J. & Toppmeyer, D. Triple-negative breast cancers and the human mammary epithelial cell hierarchy. Breast Dis. 32, 49-61 (2010).
15. Alkatout, I. et al. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer. Exp. Mol. Pathol. 94, 168-173 (2012).
16. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
17. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559-1564 (2011).
18. Wicha, M. S., Liu, S. & Dontu, G. Cancer stem cells: an old idea - A paradigm shift. Cancer Res. 66, 1883-1890 (2006).
19. Tang, J. et al. Tuning electronic properties of metallic atom in bondage to a nanospace. J Phys. Chem. B 109, 8779-8785 (2005).
20. He, H., Zheng, L., Jin, P. & Yang, M. The structural stability of polyhydroxylated C60(OH)24: Density functional theory characterizations. Comput. Theor. Chem. 974, 16-20 (2011).
21. Zhang, J. et al. Most stable structures of polyhydroxylated endohedral metallofullerene Gd@C82(OH)x (x?1-24) from density function theory. Chem. Phys. Lett. 492, 68-70 (2010).
22. Lao, F. et al. Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. ACS Nano 3, 3358-3368 (2009).
23. Yin, J. J. et al. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials 30, 611-621 (2009).
24. Conesa, A. et al. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 21, 3674-3676 (2005).
25. Semenza, G. L. Oxygen sensing, homeostasis, and disease. N. Engl J. Med. 365, 537-547 (2011).
26. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
27. Gupta, P. B., Chaffer, C. L. & Weinberg, R. A. Cancer stem cells: mirage or reality? Nat. Med. 15, 1010-1012 (2009).
28. Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
29. Chen, D. et al. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer. Cancer Res. 73, 5821-5833 (2013).
30. Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007).
31. Conley, S. J. et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc. Natl Acad. Sci. USA 109, 2784-2789 (2012).
32. Pickup, M., Novitskiy, S. & Moses, H. L. The roles of TGFb in the tumour microenvironment. Nat. Rev. Cancer 13, 788-799 (2013).
33. Pistollato, F. et al. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 28, 851-862 (2010).
34. Grotenhuis, B. A., Wijnhoven, B. P. & van Lanschot, J. J. Cancer stem cells and their potential implications for the treatment of solid tumors. J. Surg. Oncol. 106, 209-215 (2012).
35. Liu, S. & Wicha, M. S. Targeting breast cancer stem cells. J. Clin. Oncol. 28, 4006-4012 (2010).
36. Hagen, T. Oxygen versus reactive oxygen in the regulation of HIF-1a: the balance tips. Biochem. Res. Int. 2012, 436981 (2012).
37. Doege, K., Heine, S., Jensen, I., Jelkmann, W. & Metzen, E. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106, 2311-2317 (2005).
38. Bell, E. L., Klimova, T. A., Eisenbart, J., Schumacker, P. T. & Chandel, N. S. Mitochondrial reactive oxygen species trigger hypoxia-inducible factordependent extension of the replicative life span during hypoxia. Mol. Cell Biol. 27, 5737-5745 (2007).
39. Jain, M. et al. Mitochondrial reactive oxygen species regulate transforming growth factor-b signaling. J. Biol. Chem. 288, 770-777 (2013).
40. Vileno, B. et al. Spectroscopic and photophysical properties of a highly derivatized C60 fullerol. Adv. Funct. Mater. 16, 120-128 (2006).
41. Brant, J. A., Robichaund, C. O. & Wiesner, M. Fullerol cluster formation in aqueous solutions: Implications for environmental release. J. Colloid Interface Sci. 314, 281-288 (2007).
42. Wang, Z. Z. et al. A precision structural model for fullerenols. Chem. Sci. 5, 2940-2948 (2014).
43. Aleksandar, D. & Gordana, B. Fullerenol: A new nanopharmaceutic? Arch. Oncol. 16, 42-45 (2008).
44. Qiu, Y. et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31, 7606-7619 (2010).
45. Ayush, V. & Francesco, S. Effect of surface properties on nanoparticle-cell interactions. Small. 6, 12-21 (2010).
46. Wang, J. et al. Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice. Biochem. Pharmacol. 71, 872-881 (2006).
47. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
48. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (2007).
49. Chan, C. H. et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat. Cell Biol. 12, 457-467 (2010).
50. Png, K. J. et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190-194 (2011).
51. Lang, J. Y. et al. BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment. Cancer Cell 20, 341-356 (2011).
52. Liu, S. L. et al. MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet. 8, e1002751 (2012).